Glutamatergic dysfunction is an important factor in schizophrenia onset, and SV2A density and glutamate levels in anterior cingulate cortex and hippocampus have been measured in patients with schizophrenia compared to healthy volunteers with [11C]UCB-J PET. Here, SV2A is linked to schizophrenia.